10x Genomics
TXG
#4501
Rank
A$2.79 B
Marketcap
$23.06
Share price
-4.91%
Change (1 day)
-59.49%
Change (1 year)

10x Genomics (TXG) - Cash on Hand

Cash on Hand as of September 2024 : A$0.61 Billion

According to 10x Genomics 's latest financial reports the company has A$0.61 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

10x Genomics - Cash on Hand chart (from 2018 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31A$0.57 B-9.71%
2022-12-31A$0.63 B-22.02%
2021-12-31A$0.81 B-6.11%
2020-12-31A$0.86 B42.45%
2019-12-31A$0.60 B555.79%
2018-12-31A$92.38 M50.7%
2017-12-31A$61.3 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$1.48 B 141.08% Jersey
A$1.62 B 163.61%๐Ÿ‡บ๐Ÿ‡ธ USA
A$9.56 M-98.45%๐Ÿ‡บ๐Ÿ‡ธ USA
A$0.19 B-68.50%๐Ÿ‡ฌ๐Ÿ‡ง UK